Tuesday, April 5, 2016

ACC: Novel CIN Drug Goes to the 'Graveyard'

(MedPage Today) -- CMX-2043 did not reduce contrast-induced nephropathy in PCI
via ACC: Novel CIN Drug Goes to the 'Graveyard'
by

No comments:

Post a Comment